Acertara Acoustic Laboratories, a Longmont, Colo.-based, independent ISO/IEC 17025:2005 accredited medical ultrasound acoustic measurement, testing, and calibration laboratory, and ISO13485:2003 certified probe repair and new product development facility, announces that its Research and Development team has recently been awarded U.S. Patent No. 9,983,175, which is related to a device used for testing diagnostic ultrasound probes.
It is the 43rd international and U.S. patent awarded to Acertara related to diagnostic ultrasound systems and probe-testing devices notes the company’s president and chief executive officer, G. Wayne Moore.
“Our engineering team first developed the modern ultrasound probe testing paradigm more than 20 years ago when we introduced FirstCall at Sonora Medical Systems,” Moore says.
Redesigning the probe testing market by creating disruptive technologies that match the very complex and sophisticated ultrasound probes being used today, including 2D matrix arrays, single crystal arrays, and cMUT arrays, is the company’s focus, he adds.
“Our team is focused on the continuing challenge of taking our test equipment product development legacy to the next level and creating products that ensure the safety and efficacy of ultrasound probes and systems for our most important customers–patients,” Moore says. “We have already made significant strides in that area by our introduction of the Aureon and ATLAS devices, both of which have patents issued as well as multiple patents pending.”
Other patents Acertara has earned range from 3D ultrasound devices and complex test devices to devices that deliver super-saturated levels of oxygen, to myocardial tissue of heart attack patients.